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ABSTRACT 
 
THE RELATIONSHIP BETWEEN HEALTHCARE SERVICES AND  
FINANCIAL BURDEN AMONG FAMILIES OF CHILDREN WITH  
AUTISM SPECTRUM DISORDERS: A US PERSPECTIVE 
 
 
By 
Darshini Shah 
December 2016 
 
Thesis supervised by Dr. Vincent Giannetti 
OBJECTIVE: The research was designed to determine the financial burden among 
families of children with ASD and to identify the predictors of financial burden 
METHODS: Children with a confirmed diagnosis of ASD were identified in the 
Interaction Autism Network Registry. Multiple regression analyses was used to 
determine the association between financial burden and coordination of care, quality of 
healthcare interactions, adequacy of insurance, and adequacy of medical insurance 
coverage  
RESULTS: Families of children diagnosed as having ASD reported higher financial 
burden as compared to other developmental disorders. The financial burden was 
significantly associated with various facets of healthcare provision 
CONCLUSIONS: The findings highlight the role of coordinated care, access to care, and 
quality of healthcare interactions in improving caregiver burden. 
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CHAPTER ONE – INTRODUCTION 
 
Background 
Autism Spectrum Disorders (ASD) is a group of neurological disorders caused by the 
atypical development of the brain in early childhood.1 ASD is characterized by 
impairment in communication such as providing inappropriate responses in 
conversations, misreading nonverbal interactions, or having difficulty building 
friendships appropriate to their age.2 In addition, people with ASD may be overly 
dependent on routines, highly sensitive to changes in their environment, or intensely 
focused on inappropriate items.2 This is cause for concern as it may lead to significant 
difficulties in learning essential skills and living independently. ASD is known to be a 
spectrum disorder because not all ASD patients manifest the same symptoms; instead 
patients usually present varying number of symptoms and with a varying level of 
severity. According to the Diagnostic Statistical Manual (DSM) – V criteria, people with 
ASD must show these symptoms starting from early childhood, even if they are 
recognized later in life.2  
Burden of illness 
The prevalence estimates vary based on the method of estimation. In 2014, the proportion 
of children between the ages of 3-17 years diagnosed with ASD in the United States (US) 
was estimated to be 1 in 45. Additionally, the prevalence of ASD among 8-year olds has 
been estimated to be 1 in 68.3,4 ASD occurs more frequently among boys as compared to 
girls with a an estimated male-to-female prevalence ratio of 3:1 nationwide.4 Among the 
overall ASD population, the distribution by race/ethnicity was estimated to be 55.3% in 
non-Hispanic Caucasians, 20.9% in non-Hispanic African-Americans and 18.9% in 
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Hispanic children.4   The prevalence of ASD in the US has recently risen, increasing from 
6.7 per 1000 in 2000 to 14.7 per 1000 persons in 2010.4,5 The rise in prevalence, in part, 
may be attributed to the availability of better diagnostic instruments, such as Autism 
Diagnostic Observation Schedule (ADOS) and Modified Checklist for Autism in 
Toddlers, Revised (M-CHAT-R).4 However, even after accounting for the availability of 
better diagnostic instruments, the rise in ASD prevalence has been higher than expected 
and has caused concern among policymakers.4  
Cost of illness 
The annual societal cost of ASD in the US is estimated to be $137 billion.6 Societal costs 
include all costs borne by all stakeholders such as direct medical costs, direct non-
medical costs, and indirect costs.6 In 2011, the total annual cost of caring for a child with 
ASD was estimated to be $17,000 higher than the cost of caring for a child without 
ASD.6 The lifetime societal cost of autism in the US has been calculated at approximately 
$3.2 million for one child using 2003 data, with the majority of ASD-related costs 
attributable to lost productivity of patients during the course of their lifetime.7  
Direct costs 
Direct costs include healthcare costs and all costs not directly related to medical services 
such as transportation and special educational services.8,9 In the year 1999-2000, the total 
annual healthcare cost in the US children with autism vs. children without ASD was 
found to be $6,132 vs. $860, respectively.8,9 Another study found that the main predictors 
of costs were school services with  nearly 76% children with ASD receiving specialized 
educational program as compared to 8% children without ASD, thereby, accounting for 
$8610 in higher costs among children with ASD. Furthermore, the costs were also found 
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to vary significantly by the level of severity, with the most severe patients reporting 
highest non-healthcare costs in all categories (Figure 1).10   
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Figure 1: Regression-adjusted differences in non–healthcare costs for children with 
ASD compared with children without ASD, by severity and diagnostic subgroups  
 
Adapted from Lavelle et. al. 201410 
Indirect costs 
Indirect costs are opportunity attributable to work productivity due to a health disorder or 
due to taking care of someone with a health disorder.11 Based on studies using national 
samples from 2002-2008, families of children with autism were found to earn 28% less 
overall as compared to families of children without developmental problems and 21% 
less than families of children with another health limitation.6 The difference is more stark 
in case of mothers of children with autism, with 56% less earnings as compared to 
mothers of children with no limitations, and 35% less than mothers of children with 
another health limitation.6 Another study observed that while there was no significant 
difference in caregiving time with families of children with and without ASD, families of 
children with ASD reported greater time on ASD-specific caregiving activities such as 
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family-based therapies and coordinating medical services and less time on general 
activities of daily living and caregiving as compared to children without ASD.10 
Causes and Risk Factors 
Despite significant research, the etiology of ASD remains unclear. Current evidence 
suggests that ASD may be caused by a mix of genetic and environmental factors. Studies 
have reported that there is a 36-92% chance of being affected by ASD if an identical twin 
has an ASD and upto 31% chance if a non-identical twin has an ASD.12–15 Additionally, 
siblings of children with ASD have a 2-18% of being affected by ASD.16,17 This suggests 
that there may be a genetic basis for the causation of  ASD.  However, the absence of 
100% concordance of ASD among identical twins suggests that environmental factors in 
addition to genetic mutations may be involved in the causation of autism. Environmental 
factors can be classified into three types of exposures: prenatal, perinatal, and neonatal.18 
Prenatal exposures are chemicals or microbes that a child may be exposed to during the 
gestation period. An increased incidence of ASD was identified in children with prenatal 
exposure to thalidomide,  hospitalization due to infection, rubella infection, misoprostol, 
chlorpyrifos, and valproic acid.19–28  In addition to medication exposures, increased 
incidence of ASD was found in the children whose mothers had metabolic disorders such 
as diabetes, hypertension and obesity during pregnancy. In particular, obese women were 
1.6 times more likely to give birth to a child with an ASD or a neurodevelopmental 
disorder than women who were not obese.29,30 In addition, inefficient folate metabolism 
coupled with low folic acid intake during pregnancy was associated with an increased 
risk of ASD.31 Other prenatal factors that have been found to be linked with ASD are 
advanced parental age at birth and parity.30,32–35  Perinatal factors comprise of events or 
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exposures that occur during birth. Perinatal factors that inflict a higher  risk of ASD  are 
prolonged labor, breech presentation, injury or trauma during birth, maternal hemorrhage 
and gestational age with preterm babies being more likely to have ASD.34,36–38 In 
addition, children with low birth weight were twice as likely to have ASD as compared to 
children with normal birth weight. Neonatal factors are disease conditions or exposures 
after birth  such as having a heart dysfunction, infection, respiratory distress, and anemia. 
Seizures occurring early in life were associated with an increased risk of ASD.30,37  
Despite concerns about the possibility of links between vaccines and ASD, studies 
conducted by the Center for Disease Control and Prevention (CDC) and Institute of 
Medicine (IOM) have shown that vaccines do not cause ASD.39   
Diagnosis 
There is no reliable biological test for the diagnosis of ASD as no biomarker(s) have been 
identified that specifically indicate the presence of autism. As a result, the diagnosis is 
dependent on observation alone. As per DSM-V criteria, an autism diagnosis can be 
made if a child is known to exhibit persistent deficit in social communication and 
repetitive behaviors, starting in early childhood, which cannot be accounted for by 
intellectual disability or global developmental disorder. The severity of ASD is further 
classified on the basis of the level of support required: 
 Severity level 1: Requiring some support 
 Severity level 2: Requiring substantial support 
 Severity level 3: Requiring very substantial support  
It is worth noting that the DSM-V classification of ASD differs from the earlier 
classification, the DSM-IV TR criteria. The DSM-V classification no longer divides ASD 
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into three different disease entities: Autistic disorder (AD), Asperger’s syndrome and 
Pervasive developmental disorder – Not Otherwise Specified (PDD-NOS). Instead, under 
the new classification system, all ASDs are classified as one disease entity with differing 
levels of severity.40  
Early diagnosis of ASD is critical for a number of reasons. The most important reason is 
that early interventions have shown to improve the functioning in children with ASD.41 In 
addition, there is evidence that early interventions have better long-term prognosis and 
are cost-effective.42 In 2001, the average age at diagnosis was 5 years.41 With increasing 
awareness of ASD and the development of new reliable and valid instruments such as 
Autism Diagnostic Observation Schedule (ADOS) for diagnosis, a large number of 
children are being diagnosed earlier. The average age for diagnosis of autism was 3.1 
years in 2004.41 Studies have shown that a reliable and valid diagnosis for autism in a 
child can be obtained at 2 years. The diagnosis obtained at 2 years was found to be stable 
at the age of 9 years.41 The two commonly used instruments for diagnosis are: Autism 
Diagnostic Interview-Revised (ADI-R) and Autism Diagnostic Observation Schedule 
(ADOS).43,44,45ADI-R is a semi-structured interview which is administered to parents by 
the clinician. The instrument is appropriate for administration in reference to any child 
whose mental age is at least 18 months.44 ADOS is used in a clinical environment to 
establish a diagnosis based on observation and interaction with the child. The instrument 
relies on the use of age appropriate play activities to establish a diagnosis. ADOS has 
been widely regarded as a gold standard for the diagnosis of ASD; however, it has limited 
applicability in  toddlers.45 Newer diagnostic tools such as M-CHAT and ADOS-2 have 
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been designed with a goal of obtaining a reliable diagnosis of autism in toddlers as young 
as 16-30 months old.46,47  
Disease Management 
The symptoms of ASD include impairments in three core domains, including social 
skills, language, and behavior. In addition, there may also be deficits in cognitive ability 
and sensory perceptions among children. ASD represents a spectrum of disorders, which 
means that patients may exhibit a different number of core and allied symptoms and the 
levels of severity of deficits may differ as well. Accordingly, interventions may be 
targeted at alleviating deficits in core symptoms or one of the allied symptoms or a 
combination of treatments may be utilized.48,49 Treatment goals are based on the 
symptoms manifested. Interventions are usually designed to achieve one of the following: 
1. Improving functional abilities in one or more of the following domains: 
academic skills, communication skills, higher cognitive function, interpersonal 
skills, learning readiness, motor skills, personal responsibility, play, placement in 
schools, self-regulation.48   
2. Reducing undesirable behaviors: such as problem behaviors, restricted, 
repetitive, nonfunctional patterns of behavior, interests, or activity (RRN).48  
Generally, interventions may focus on one or more of the areas mentioned above. 
Interventions for ASD are divided into five categories: behavioral, educational, medical 
and related, allied health, and complementary and alternative medicine.  
1. Behavioral interventions: Over the course of their development, children tend to 
experiment with behaviors. The behaviors may be acceptable or unacceptable.50  
Usually, the acceptable behaviors are encouraged by subtle positive 
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reinforcements and the unacceptable behaviors are discouraged by punishments of 
negative reinforcements.50  Children with ASD have difficulty interpreting the 
environmental stimuli and hence, intensive behavioral interventions are needed.50 
Behavioral interventions are based on the principles of applied behavioral analysis 
(ABA).51 ABA is focused on teaching children to maintain performance of 
acceptable behaviors and reduce unacceptable behaviors. ABA uses 
reinforcement, shaping, prompting and prompt-fading, and generalization as 
teaching techniques.51 In addition, ABA helps children maintain the behaviors 
taught in different settings. There is preliminary evidence that early intensive 
behavior and developmental interventions improve core deficits among children 
with ASD.44–54 Interventions that fall in this category are: University of California 
Los Angeles (UCLA)/Lovaas model, Early Start Denver Model, Pivotal Response 
Treatment, Joint Attention Intervention, and Cognitive Behavioral Treatment.49 
2. Educational interventions: Educational interventions are administered primarily in 
an educational setting with the intent of improving academic and cognitive skills. 
The main focus is improving personal independence and social responsibility.49, 63   
Some programs have focused on addressing social and behavioral issues arising in 
the classroom setting.64  The most widely applied educational intervention is the 
Treatment and Education of Autistic and Communication-related Handicapped 
Children (TEACCH) program.64 TEACCH involves structured teaching which is 
based on the fact that children on the spectrum have difficulty in perception and 
understanding. As a result, the teaching methods incorporate picture schedules 
and physical supports that provide a unique learning opportunity for children.64 In 
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general, educational interventions are classroom-based or computer-based 
approaches usually based on the principles of ABA such as providing 
reinforcements to help children learn.49  
3. Medical and related intervention: Medical and related interventions is a category 
of interventions that comprises any intervention involving the administration of an 
external substance to treat the symptoms of ASD.48,49 Medical and related 
intervention include medications, supplements, specialized diets or other 
treatments such as hyperbaric oxygen.48,49 The medications that are most 
commonly used to treat symptoms of ASD are antipsychotics, serotonin reuptake 
inhibitors (SRI) and psychostimulants.48,49 Other medical interventions such as 
immunoglobulin, hormonal treatments and gluten free casein free diets have also 
been used to treat ASD.48,49 Medical and related interventions are generally 
recommended for children with severe behavioral problem.48,49 Antipsychotics, 
SRI and psychostimulants act by controlling hyperactivity and challenging 
behaviors.48,49 Medications are often used in conjunction with other behavioral 
and allied health interventions.48,49  
4. Allied health interventions: Allied health interventions are aimed at overcoming 
core deficits of ASD.48,49 These interventions are roughly divided into three 
categories: interventions to improve language, sensory or auditory integration 
techniques, and other approaches that address multiple limitations.48,49 These are 
administered by allied health professionals such as speech therapist, physical 
therapist, and occupational therapist.48,49 Few examples of allied health 
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interventions are: sensory integrations, auditory integrations, speech therapy, 
music therapy, and picture exchange communication systems.48,49     
5. Complementary Alternative Medicine (CAM): CAM interventions comprises an 
array of healthcare approaches outside mainstream western medicine that may be 
used along with or in place of conventional medicine.48,49 Use of CAM therapies 
is common in children with ASD.48,49 The therapies that have been known to be 
used in ASD are aromatherapy, dance therapy, massage therapy, acupuncture. The 
modality of action of these interventions is not known.48,49  
Problem statement 
Due to the spectrum of disabilities in children with ASD, the treatment protocol for each 
child is individualized and diverse. Often times, children are simultaneously prescribed a 
number of treatments to tackle different issues. Due to treatment complexity, parents 
have to spend a significant amount to time arranging and coordinating treatment. In 
addition, parents act as informal caregivers and provide specialized care at home. As 
such, parents take on multiple roles within caregiving. Meeting the high care demands of 
children with ASD requires much time, effort and patience.  This often results in 
psychological distress, depression, anxiety and other mental or physical health problems 
in parents.65,66 Moreover, due to the high out-of-pocket healthcare expenses, inadequacy 
of insurance, underemployment or employment loss, families of children with ASD face 
financial problems.6,67 High financial burden can have a significant negative impact on 
several aspects of the caregiver’s as well as child’s life, including early 
institutionalization. It is important to understand the predictors of financial burden in 
order to find strategies to lower caregiver burden among informal caregivers. Quality of 
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healthcare interactions and coordination of care are two important aspects of healthcare in 
children with ASD. Identifying predictors can help improve disease management in these 
patients. 
Hypothesis 
The overall hypothesis of the study is that certain aspects of the healthcare system, such 
as coordination of care, access to care, and quality of healthcare interactions are likely to 
contribute significantly to the financial burden. Coordination of care and quality of 
healthcare interactions are, in turn, likely to be affected by adequacy of insurance, 
severity of disease, and number of co-morbidities. 
Research questions 
1. To determine the economic impact of ASD on the families of children with ASD 
2. To determine the relationship between financial burden among families of 
children with ASD and coordination of care, unmet needs, access to care, quality 
of health interactions, and adequacy of insurance 
3. To determine the relationship between quality of healthcare interactions and 
access to care, adequacy of insurance, unmet needs, coordination of care, and 
severity of disease 
4. To determine the relationship between coordination of care and ease of obtaining 
a referral, access to care, adequacy of insurance, unmet needs, quality of 
healthcare interactions, and severity of disease 
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CHAPTER TWO – LITERATURE REVIEW 
A detailed literature review was conducted to identify and understand the existing 
literature related to caregiver burden, quality of care, and the cost of ASD.  
Search strategy and inclusion / exclusion criteria 
Relevant publications were identified through a search of the literature with PUBMED 
using the following search terms: (1) Autism* or ASD* or autistic* in combination with 
(1) cost or economic* (2) caregiver burden* or caregiving* (3) quality of care* or quality 
of healthcare*. Human studies in English language conducted in the US and published in 
peer-reviewed journals were included in the initial search. The search was restricted to 
January 2006 – January 2016. The search yielded 506 hits, to which the following 
exclusion criteria were applied: (1) non-original research such as letters, commentaries or 
reviews, (2) not focused on ASD, or (3) not focused on caregiver burden, quality of care 
or epidemiology. The details of the literature review are described in Figure 2. 
  
14 
 
 
 
  
Autism + (Caregiver burden OR 
Quality of care OR epidemiology OR 
economic): 506 hits 
 
161 titles selected for further abstract 
review 
345 excluded on the 
basis of title review 
101 abstracts selected for full-article 
review 
60 excluded on the basis 
of abstract review 
35 articles included in the full study 
 41 studies conducted 
outside the US 
 4 not original researches 
(letters, commentaries, 
review, etc.) 
 2 not in children 
 5 articles not relevant to 
the topics focused on in 
the thesis 
 14 not relevant to the 
topic 
Figure 2: PRISMA diagram for literature review 
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Caregiver burden 
Meeting the high care demands of children with ASD requires time, effort, and patience. 
In addition, parents of children are faced with serious concerns about the child’s future, 
bullying, and the child’s learning abilities.68 This often results in psychological distress, 
depression, anxiety and other mental or physical health problems among parents.65,66 
Moreover, due to the high out-of-pocket healthcare expenses and underemployment or 
employment loss, families of children with ASD face financial problems.6,67 It is 
important to measure the caregiver burden in these settings, as caregiver burden and 
parenting stress can have an impact on the caregivers’ ability to care for the child, 
especially their ability to provide behavioral treatments. Studies measuring the quality of 
life among caregivers showed that caregivers of children with ASD showed that a 
significant proportion of patients with ASD had mental (58%), physical (52%) and 
financial problems (56%). A majority of caregivers (61%) had difficulty combining 
activities of daily living and ASD-specific tasks. The measurement of health-related 
quality of life (HRQoL) and health utilities showed that caregiver of children with ASD 
had significantly lower HRQoL and utilities as compared to the US population.65,69 The 
main predictors of caregiver burden may be classified into three categories: child-related 
factors, parental factors, and environmental factors. Child-related factors that have been 
found to be predictors of caregiver burden are deficits/delays in children’s social 
relatedness70,71, child’s sensory-related problems72  and  presence of comorbidities.73,74 
Parental correlates associated with caregiver burden include parenting efficacy, social 
support, parental attributions, coping styles, and resilience. Environmental factors include 
respite care and time since child’s ASD diagnosis. 
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Economic burden associated with ASD 
Nineteen studies relevant to the economic burden were identified by the literature review. 
The studies provided information on financial burden faced by families as well as the 
economic burden on the healthcare system.  
Financial burden on families 
The average lifetime cost of ASD has been estimated to be $3.2 million, with the 
majority of costs being attributed to lost productivity among adults with ASD and parents 
of children with ASD.7 Another study found that the discounted lifetime costs for patients 
with an ASD diagnosis without intellectual disability were $1.43 million in the US.75 The 
estimated loss of income has been estimated to be between 14% and 28%.6,67 On average, 
mothers of children with ASD earn 35% ($7,189) less than the mothers of children with 
another health limitation and 56% ($14,755) less than the mothers of children with no 
health limitation.6 The annual societal cost of childhood ASD was also found to be higher 
by $17,000 than that in children without ASD and was higher as compared to cost of 
depression, spina bifida, and mental retardation. 10,8,76 Insurance coverage and type of 
insurance are both important predictors of financial burden among families. A higher per 
capita Medicaid spending in the state was associated with a lower family burden.77 The 
out-of-pocket costs were significantly lower among individuals insured by Medicaid as 
compared to privately insured individuals.78 Families of children living in states with 
mandates requiring the coverage for ASD were 29% less likely to have out-of-pocket cost 
greater than $500.79 
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Healthcare utilization and economic burden on the healthcare system 
Studies have shown that the healthcare utilization and the cost of healthcare of ASD in 
children was found to be higher as compared to healthcare utilization in children without 
ASD.8,9 The total annual healthcare cost in the US for children with ASD vs. children 
without ASD was found to be $6,132 vs. $860 in the year 1999-2000 and has increased 
over the years, showing a 20.4% increase from 2000-2004.80 Similar results were 
observed in a population of Medicaid patients with the annual cost of healthcare 
increasing from $22,079 in 2000 to $22,772 in 2003.81 The annual total charges of 
hospitalization in children with ASD was estimated to be $24,862 in 2007.82 Predictors of 
costs were identified in several studies. The main predictors of cost in children with ASD 
were found to be age, insurance coverage, and the presence of co-morbidities. Another 
potential predictor is the state of residence, whose impact was not well-established with 
two studies implying no impact on financial burden and two studies demonstrating a 
significant variation in financial burden based on the state of residence.83,84,85,79 There 
was significant difference between healthcare cost to private payers and Medicaid, with 
cost being almost four times higher among children insured by Medicaid as compared to 
privately insured individuals ($22,653 vs. $5,254, p<0.0001).86 The biggest component of 
the cost difference across Medicaid and private insurance was in outpatient services 
($19,948 vs. $3,045, p<0.0001). Psychiatric care costs were over five times higher in 
Medicaid than in private insurance ($12,851 vs. $2,293, p<0.0001) and were responsible 
for a larger fraction of total healthcare costs (57% vs. 44% per child with ASD, 
respectively). Most of this difference in psychiatric care costs was due to differences in 
outpatient costs. ASD-specific service costs were eight times higher in Medicaid than in 
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the private sector ($7,438 vs. $928, p<0.0001). Medicaid patients also received 
significantly more visits for OT/PT, speech therapy and behavior modification treatment 
than patients enrolled in private insurance.86 Based on a study conducted in Pennsylvania, 
it is likely that the passage of a mandate requiring private insurance to cover ASD-related 
services may reduce state Medicaid expenditures.87 Another predictor of the medical 
expenditures associated with ASD was found to be the presence of comorbidities. The 
type of comorbidities had a significant impact on medical expenditures, with intellectual 
disability being associated with the highest cost in children with ASD (Figure 3). 
Discounted lifetime costs for someone with an ASD diagnosis and intellectual disability 
were $2.44 million in the US.75 Moreover, the predictors of healthcare costs changed over 
the course of a lifetime. The utilization of outpatient services significantly declined with 
each year of age for occupational/physical therapy (9%), speech therapy (8%), mental 
health services (2%), diagnostic/assessment services (2%), and family therapy (3%). 
Utilization significantly increased with age for case management/service coordination 
(2%), medication management (6%), personal care/home health aide (1%), day 
treatment/partial hospitalization (4%), and respite services (3%). The most dramatic 
changes in service utilization occurred between the 3–6 year-old and 7–11 year-old age 
cohorts.88 
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Figure 3: Medical expenditures associated with co-morbidities 
  
Adapted from Peacock et. al. 201289 
Quality of care in ASD 
Six studies relevant to the quality of care were identified; of these, four studies focused 
on quality of care in patients with ASD and two studies on the overall quality of care 
among all children and the predictors. Parental perception of medical encounters is 
increasingly recognized as an important measure of quality care. Higher patient/caregiver 
satisfaction with physician interaction can enhance their involvement in self-
management.90 A study conducted among Latino children in the US found that healthcare 
utilization was mediated by provider interactions.91 Studies have reported that the quality 
of healthcare is lower in children with ASD. A single US center in 2002-2003 found that 
parents of children with ASD reported lower satisfaction with their primary care 
physicians as compared to parents of children with other developmental disabilities as 
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well as parents of children with mental retardation. Compared to parents of children with 
developmental disabilities or mental retardation, parents of children with ASD rated their 
physicians as worse in terms of physician’s ability to answer questions about the child’s 
condition, ability to understand how the child’s condition affects the family, and their 
knowledge of complementary and alternative medicine.92 A study based on a nationally 
representative data collected in 2003 demonstrated that patients with ASD were less 
likely to have a medical home as compared to patients without ASD.90 In another study 
based on a nationally representative sample of children with special healthcare needs in 
the US conducted in 2009-10, quality of care was measured based on three parameters – 
shared decision-making, coordination of care, and availability of routine care, was lower 
in children with ASD, with a greater proportion of caregivers of children with ASDs 
reporting lack of shared decision making (43.1%), as compared to caregivers of children 
with developmental disabilities (36.4%) and mental health conditions (31.1%). A 
significantly greater proportion of caregivers of children with ASDs reported lack of 
coordination (86.7%) as compared to all other groups (82.2% DDs, 61.0% MHCs, and 
80.2% both DDs/MHCs).93 The caregivers of these patients were likely to experience a 
higher adverse impact.94 Based on a quality of care study, children with ASD were least 
likely to have positive scores on the minimal quality index, with only 22% scoring 
positively. The minimal quality index includes adequacy of insurance, insurance 
consistency, preventive medical care visits, preventive dental care visits, development 
screening for young children, access to mental health specialists, and medical home.95 
The age of diagnosis has been considered to be another proxy for quality of care. The age 
at diagnosis among Medicaid-enrolled children in the US from 2002-2004 was observed 
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to be around 5.4 years.96 Over the three years of the study, the age at diagnosis decreased 
by 5 months, indicating an improvement in quality of care over time but still more 
delayed than it should have been.96     
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CHAPTER THREE – METHODS 
 
The study was a cross-sectional retrospective database study conducted using data from 
the Interactive Autism Network (IAN). 
Data source  
Data for the study were obtained from elective online surveys created and hosted by the 
IAN. IAN is an innovative project bringing together patients and caregivers affected by 
ASD and researchers involved in ASD research. The IAN research database consists of 
54,000 registered members. The members of IAN submit baseline data at joining, such as 
age of subject, first ASD diagnosis, gender, ethnicity, birth year, race, and state of 
residence. Following registration, IAN periodically fields questionnaires to members, 
who may elect participation. Several datasets are maintained by the IAN consisting of 
questions related to children with ASD, or parents and siblings of children with ASD. 
The current study is based on general data collected at baseline, detailed diagnosis data, 
and a survey focused on healthcare access-related issues. The questionnaires used to 
collect data were either standardized questionnaires, or questionnaires developed in 
consultation with subject experts. The data used in the study is cross-sectional and has 
been collected from 2009-2010.97 Detailed information about the datasets used in this 
study is described below: 
 Subjects: The dataset consists of demographic information about the subject who 
has been diagnosed with ASD. The variables included in this dataset that were 
used in the analysis are 
o Age of subject (child) 
o Gender 
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o Ethnicity 
o Race 
o State of residence   
 Child with ASD: This dataset is focused on the medical history of the child who 
has been diagnosed with ASD. The questionnaire used to collect the data was 
administered to parents of the child with ASD. The questionnaire consisted of 65 
questions and took approximately 15 mins to complete. The questions are 
primarily related to the child’s medical history and ASD diagnosis, such as age at 
first ASD diagnosis, ASD diagnosis, healthcare professional who diagnosed ASD, 
diagnosis of comorbidities, history of ASD among siblings and cousins. The 
variables from this questionnaire that were used in the analysis are 
o Year of first ASD diagnosis  
o Number and type of comorbidities 
 Social Communication Questionnaire (SCQ): This dataset is a standardized 
questionnaire screening instrument that is used to help identify which children 
may have ASD. The questionnaire consists of 40 yes/no questions designed to 
understand the child’s body movements, use of language or gestures, and style of 
interacting. A SCQ score is known to be correlated with a diagnosis of ASD, with 
a higher score indicating a higher likelihood of an ASD diagnosis.98 There are two 
versions of SCQ – lifetime and current. The lifetime SCQ scores were used in the 
analysis to provide information about the entire developmental history of the 
child.98 The questionnaire is administered to the parents of the child at the time of 
registration and can be completed in about 10 mins.98 The SCQ consists of three 
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domains – behavior, communication, and social interactions. The cut-off score for 
SCQ has been determined to be 15, with a sensitivity of 0.71 and a specificity of 
0.75. SCQ has demonstrated good discriminative validity between ASD and other 
disorders including non-autistic mild or moderate mental retardation.98 The total 
SCQ score and the total score on each of the domains was used for the analysis.98  
 Social Responsiveness Scale The Social Responsiveness Scale (SRS), an 
important instrument for measuring the social aspects of ASD, is a 65-item rating 
scale assessing characteristic autistic behavior. Each item is scored from 0 (‘never 
true’) to 3 (‘almost always true’) describing the child’s behavior in the past 6 
months.99 Total scores can range from 0 to 195.99 The cut-off point that best 
discriminates children with and without ASD (≥75) was chosen SRS scores 
discriminate between children with and without ASD and are strongly correlated 
with the autism diagnostic interview – revised (ADI-R) domain scores (r = 0.65 to 
0.77).99 The SRS is easy to administer and is administered to parents of children 
aged 4-18 years.99 The administration time is approximately 15 mins. The 
variables that were used in the analysis are SRS total score, SRS t-score, and the 
total and normalized scores on each of the domains.99  
 Access to care: This dataset is focused on understanding the barriers to treatment 
in children with ASD. The dataset contains information about the following 
concepts: 
o Care coordination 
o Family-centered care 
o Transition issues 
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o Impact on the family 
Data access and ethics  
The de-identified data was accessed by submitting a data service use agreement and the 
study was provided an exempt status from the Duquesne University Institutional Review 
Board (IRB).   
Data extraction   
The data extraction and analysis was conducted using the software SAS 9.4® (SAS 
Institute; Cary, NC). The study population consisted of children (age < 18 years) who had 
a confirmed diagnosis of ASD by a healthcare professional. The five datasets were 
merged using the variable ‘IAN research ID’. Only children who had complete responses 
on all five questionnaires were included in the analysis.  Records with ≥15% missing data 
were excluded from the analysis.   
Description of variables  
Variables relevant to the analysis are described in the following section. 
Age of child  
Respondents were asked to specify the age of the child with ASD at listing, which was 
recorded as age_at_listing. The variable age_in_years was calculated based on the age at 
listing and the time since listing.  Age_in_years was defined as a continuous variable. 
Age at diagnosis  
Respondents were asked to specify the age at which the child was first diagnosed. This 
variable was recorded as age_first_diagnosis.  Age_first_diagnosis was defined as a 
continuous variable. 
Gender of child  
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Respondents were asked to specify the gender of the child with ASD at listing. The 
variable was recorded as gender. Gender was defined as a categorical variable with two 
levels, 0 and 1, with 0 corresponding to male and 1 corresponding to female.  
Race of child  
Respondents were allowed to select multiple races. Race of the child was recorded by 
means of several categorical variables. Each variable had two levels, 0 and 1, with 1 
corresponding to belonging to a particular race. The races recorded are American Indians 
and Alaska Natives (race_ai_an), Asian (race_asian), African American 
(race_black_aa), Native Hawaiin and other Pacific Islanders (race_nh_pi), Caucasians 
(race_white), Other (race_other), and Unknown (race_unknown).  
Ethnicity of child  
Respondents were asked to specify the ethnicity of the child with ASD at listing. The 
variable was recorded as ethnicity. Ethnicity was defined as a nominal variable with two 
levels, Hispanic or Latino and Non-Hispanic 
Total household income  
The total household income was defined as the total combined income including wages, 
salaries, unemployment payments, public assistance, social security or retirement 
benefits, and help from relatives. The variable was recorded as a categorical variable, 
total_household_income.  Total_household_income was defined as a categorical variable 
with 6 levels: 1 < $10,000; 2 = $10,000-39,999; 3 = $40,000-69,999; 4 = $70,000-
99,999; 5 ≤ $100,000    
Comorbidities  
Respondents has the option of selecting multiple comorbidities. The variable 
comorbidities were recorded as comorbidities and refer to the number of comorbidities. 
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Comorbidities were calculated based on the sum of several categorical variables: motor 
delay, cerebral palsy, ADHD, depression, mental retardation, seizures, schizophrenia, 
tuberous sclerosis, anxiety disorder, and bipolar disorder. Each variable had two levels, 0 
and 1, with 1 corresponding to being diagnosed with the particular comorbidity.  
Family reduced working hours  
Respondents were asked if any family members reduced hours of working because of 
their child’s health. The variable was recorded as a categorical variable, 
cut_hours_childs_needs, with two levels (0 and 1) and 1 corresponding to someone in the 
family having to cut hours to care for the child with ASD.  
Family stopped working   
Respondents were asked if any family members stopped working because of your child’s 
health. The variable was recorded as a categorical variable, fam_stopped_working. 
Fam_stopped_working has two levels, 0 and 1, with 1 corresponding to someone in the 
family having to stop working to care for the child with ASD. 
Need more income   
Respondents were asked if they needed additional income to cover your child's care. The 
variable was recorded as a categorical variable, need_more_income, with two levels, 0 
and 1, with 1 corresponding to needing more income to care for the child with ASD. 
Financial burden   
Respondents were asked if child's care caused financial problems for the family. The 
variable was recorded as a categorical variable, child_health_fin_prob. 
Child_health_fin_prob had two levels, 0 and 1, with 1 corresponding to having financial 
problems because of child’s health. 
Out-of-pocket payments    
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Respondents were asked about the amount of money paid during the past 12 months for 
the child's care, including out-of-pocket payments for all types of health-related needs 
such as co-payments, dental or vision care, medications, special foods, adaptive clothing, 
durable equipment, home modifications, and any kind of therapy if any family members 
stopped working because of your child’s health. This variable did not include health 
insurance premiums or costs that were or would be reimbursed by insurance or another 
source. The variable was recorded as a categorical variable, family_paid_all_care. 
Family_paid_all_care had six levels: 1 = Nothing; 2 < $250; 3 = $250-499; 4 = $500-
999; 5 = $1000-4999; 6 ≥ $5000. 
Unmet needs   
Unmet needs was not formally defined in the dataset, but was created as a proxy for 
access to care for the purpose of data analysis. The variable was recorded as unmetneeds 
and defined a sum of unmet healthcare needs of the child with ASD or of the families. 
Respondents were asked about the healthcare services their child needed such as 
occupational therapy, physical therapy, prescription medicine, etc. This indicated a 
healthcare need. If the respondents answered yes, they were asked a follow-up questions 
to determine which of the healthcare needs were met. For each patient, a summation was 
performed to determine how many healthcare needs were not met. The definition of 
unmet need is illustrated using the example of mental health services and is described 
below (Figure 4). 
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Quality of health interactions    
Quality of health interactions was not defined in the dataset, but was created as a proxy 
for quality of care for the purpose of data analysis. The variable was recorded as 
qualityofcare and defined a sum of the following categorical variables: 
doctor_time_child, often_dr_listen, often_dr_sensitive, often_dr_inform, 
often_dr_partner. These variables measured how often (never, sometimes, usually, 
always) doctors or other healthcare providers spent enough time with the child, listened 
carefully to the parent/caregiver, were sensitive to family values and customs, provided 
specific information the parent/caregiver requested, and helped the parent/caregiver feel 
like a partner in the child’s care. 
Type of health insurance  
During the past 12 months, was there any time when your 
child needed mental health services or counseling? 
No 
Yes 
During this time, did your child receive all the mental health 
services or counseling he/she needed?  
No unmet need for mental health 
services or counseling 
Yes 
No 
Unmet need for mental health services or counseling 
No unmet need for mental health 
services or counseling 
Figure 4: Algorithm for determining the presence of an unmet need 
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Respondents were allowed to select multiple health insurances. Type of health insurance 
of the child was recorded by means of several categorical variables: 
type_health_insurance_1, type_health_insurance_2, type_health_insurance_3, 
type_health_insurance_4, type_health_insurance_5. Each variable had two levels, 0 and 
1, with 1 corresponding to having a particular insurance. Insurance provided through an 
employer or union was recorded as type_health_insurance_1; Medicaid was recorded as 
type_health_insurance_2; Children's Health Insurance Program (formerly known as S-
CHIP) was recorded as type_health_insurance_3; Military Health Plan was recorded as 
type_health_insurance_4; any other insurance was recorded as type_health_insurance_5. 
Adequacy of insurance  
Respondents were asked if the child’s health insurance offered benefits or covered 
services that met his/her needs. The variable was recorded as a categorical variable, 
insurance_meet_needs. Insurance_meet_needs had 4 levels – 1: Never; 2: Sometimes; 3: 
Usually; 4: Always. 
Delayed or no care  
Respondents were asked if they had delayed or gone without needed care for the child. 
The variable was recorded as a categorical variable, care_delay_without. 
Care_delay_without had 2 levels – 0: No; 1: Yes. The variable care_delay_without 
was used as a proxy for access to healthcare. 
Coordination of care  
Respondents were asked if during the past 12 months, they had felt they could have used 
extra help with arranging or coordinating child’s healthcare. The variables were 
categorical and had two levels, 0: No and 1: Yes. If they answered yes, a follow-up 
question was asked to assess how often they received sufficient help with coordination. 
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The variable had four levels – 1: Never, 2: Sometimes, 3: Usually, 4: Always. A new 
variable was created to account for the availability of sufficient coordination. The new 
variable was recorded as sufficient_coordination. Sufficient_coordination had two levels, 
0: insufficient and 1: sufficient coordination. If the response to the first question was 1, 
and the follow-up question was 3 or 4, parents were considered to have sufficient help 
with coordination.   In some situations, sufficient_coordination was reverse coded to 
create the variable insufficient_coordination.  
Social communication questionnaire   
The total score on the social communication questionnaire was recorded as scq_total. 
scq_total was a continuous variable. The dataset also contained scores on three domains 
of SCQ – social domain (social_domain), communication domain 
(communication_domain), and behavior domain (behavior_domain) 
Social responsiveness scale   
The standardized score on the SRS was recorded as srs_t_score.  srs_t_score was a 
continuous variable. The dataset also contained standardized scores on three domains of 
SRS – awareness (awareness_t_score), social cognition (social_cognition_t_score), 
social communication (social_communication_t_score), social motivation 
(social_motivation_t_score), and autistic mannerisms (autistic_mannerisms_t_score). 
Ease of obtaining a referral  
A new variable was created to account for ease of referral. The new variable was 
recorded as ease_ref. Respondents were asked if during the past 12 months, the child 
needed a referral to see any doctors or receive any services. The variable was categorical 
and had two levels, 0: No and 1: Yes. If they answered yes, a follow-up question was 
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asked to assess how much of a problem it was to get referrals. The variable had three 
levels – 1: Big problem, 2: Small problem, 3: Not a problem.  
Data analysis 
 
A descriptive analysis was conducted to identify the demographic characteristics of the 
children and caregivers including age, gender, race, ethnicity, total household income, 
comorbidities, quality of health interactions, and unmet needs. 
Research objective 1 
 
To determine the economic impact of ASD on the families of children with ASD 
 
Descriptive analyses were conducted to determine the economic impact of ASD in terms 
of employment outcomes, out-of-pocket payments, financial problems, and need for more 
income.  In addition, an analysis was conducted to measure the relationship between 
adequacy of insurance and type of health insurance, and the relationship between 
adequacy of insurance and out-of-pocket costs. A chi-square analysis was used to 
measure the relationship among the categorical variables.  
Research objective 2  
 
To determine the relationship between financial burden among families of children with 
ASD and coordination of care, unmet needs, access to care, quality of health 
interactions, adequacy of insurance 
A logistic regression analysis was used to determine the predictors of financial burden, a 
dichotomous variable, among families of children with ASD. The event selected was 1 to 
model the probability of having financial problems due to the child’s health. The 
independent variables in the analysis were adequacy of insurance, unmet needs, delaying 
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care or going without care, quality of healthcare interactions and insufficient help with 
coordination of care.  Dummy variables were used for variables with more than two 
levels. The assumptions of linear relationship, normality of residuals, and 
homoscedasticity are not applicable to logistic regression and hence were not included in 
the analysis. Multicollinearity was assessed using the convergence criterion to ensure that 
variables were related but not perfectly linear combinations of one another. The primary 
concern surrounding multicollinearity is that as the degree of multicollinearity increases, 
the regression model estimates of the coefficients become unstable and the standard 
errors for the coefficients can be inflated.  
Research objective 3  
 
To determine the relationship between quality of healthcare interactions and access to 
care, adequacy of insurance, unmet needs, coordination of care, severity of disease  
Multiple regression analysis was conducted to determine the predictors of quality of 
health interactions. Since the quality of health interactions was defined as a sum of five 
variables (doctor_time_child, often_dr_listen, often_dr_sensitive, often_dr_inform, 
often_dr_partner), an analysis was conducted to evaluate the internal consistency of the 
measure and the multi-collinearity among the variables used to define quality of 
healthcare interactions. The methods are described in three steps:  
 Internal consistency of quality of healthcare interactions scale: The internal 
consistency of the scale used to define quality of health interactions was tested by 
calculating the Cronbach’s alpha. Cronbach’s alpha is the average inter-
correlation between the individual items of the scale, and it is a measure of how 
34 
 
closely related a set of items are as a group. Cronbach’s alpha > 0.7 is considered 
acceptable. 
 Multicollinearity diagnostics for quality of health interactions scale: The 
multicollinearity of the independent variable was tested using tolerance statistic. 
The multicollinearity statistics were tested using quality of health interactions 
scale as the dependent variable and the five variables as independent. The five 
variables were categorical, hence, each variable was converted to a dummy 
variable for addition to the regression model.  
 Regression analysis to determine predictors of quality of health interactions 
scale: The method used for the regression analysis was orthogonal, which 
reduces the error sum of squares by adding a variable after all other variables 
have been added to the model. The dependent variable was quality of healthcare 
interactions. The independent variables for the regression analysis were as 
follows: adequacy of insurance, unmet needs, delaying or going without 
healthcare, sufficient help with coordination, total score on the SCQ scale, score 
on the social domain on the SCQ scale,  score on the communication domain on 
the SCQ scale, score on the behavior domain on the SCQ scale, total SRS t-score, 
t-score on the awareness domain, t-score on the social cognition domain, t-score 
on the social communication domain, t-score on the social motivation domain, 
and t-score on the autistic mannerisms domain. Dummy variables were used for 
variables with more than two levels. In order to carry out a linear regression, data 
should meet the assumption of absence of outliers, linearity, normal distribution 
of errors, homoscedasticity and multicollinearity. All independent variables of 
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importance were tested for correlation against the dependent variable. As the 
presence of outliers in the data is likely to skew the results of regression, all 
variables were checked for outliers and treated if necessary to eliminate 
observations containing outlier or capping the values between 1st-99th percentile. 
Each continuous variable was analyzed using to check for mean, standard 
deviation, and outliers and each categorical variable was analyzed using 
frequency analysis to identify any outliers. Only variables with significant 
correlation were included in the final model to meet the linear relationship 
assumption. As per the assumption of normality, the error of residuals should be 
normally distributed, and a Shapiro-Wilk’s was created using the residual values 
of the dependent variable. There also should be homogeneity of variance of the 
residuals, meaning that the variance of residuals should be approximately equal 
for all predicted dependent variable values. To check for homoscedasticity, a 
residual plot was created and it was observed that the variance was constant 
across different levels of the dependent variable. Finally, multicollinearity was 
checked by observing the collinearity diagnostics. The term collinearity implies 
that two variables are near perfect linear combinations of one another. When 
more than two variables are involved it is often called multicollinearity. The 
primary concern surrounding multicollinearity is that as the degree of 
multicollinearity increases, the regression model estimates of the coefficients 
become unstable and the standard errors for the coefficients can be extremely 
inflated. Multicollinearity was tested to ensure that variables were measuring 
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different tolerance statistics. A tolerance value of 0.1 and higher was considered 
to be acceptable. 
Research objective 4  
 
To determine the relationship between coordination of care and ease of obtaining a 
referral, access to care, adequacy of insurance, unmet needs, quality of healthcare 
interactions, severity of disease 
Logistic regression analysis was conducted to determine the predictors of having 
sufficient help with coordination of care among families of children with ASD. The 
dependent variable was sufficient help with coordination and the event selected was 1 to 
model the probability of having sufficient help with coordination of care. The 
independent variables in the analysis were adequacy of insurance, unmet needs, delaying 
or going without care, quality of healthcare interactions, ease of obtaining a referral, and 
the total SCQ score. Dummy variables were used for variables with more than two levels. 
The assumptions of linear relationship, normality of residuals, and homoscedasticity do 
not apply and hence were not included in the analysis. Multi-collinearity was assessed 
using the convergence criterion. 
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CHAPTER FOUR – RESULTS 
Descriptive analysis 
The dataset for access to care included 383 participants. The final dataset based on the 
inclusion/exclusion criteria, consisted of responses from 323 participants collected during 
the years 2009-10. The sample consisted of 82% males and 90% Caucasians. A detailed 
summary of demographic variables is described in Table 1. 
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Table 1: Demographic characteristics of the population 
Variable 
 
Level Frequency 
n (%) 
Age (years, Mean ± SD)  9.88 ± 3.77 
   
Gender Male 264 (81.7) 
 Female 59 (18.3) 
   
Race Caucasian 293 (90.7) 
 African American 14 (4.3) 
 Pacific Islander 2 (0.6) 
 American Indian or Alaskan 5 (1.5) 
 Asian 8 (2.5) 
 Other 11 (3.4) 
 Unknown 2 (0.6) 
   
Ethnicity Hispanic 23 (7.1) 
 Non-Hispanic 300 (92.9) 
   
Total household income < $10,000 11 (3.5) 
 $10,000-39,999 58 (18.7) 
 $40,000-69,999 69 (22.3) 
 $70,000-99,999 70 (22.6) 
 > $100,000 102 (32.9) 
   
Co-morbidities Motor delay 148 (45.8) 
 ADHD 101 (31.2) 
 Anxiety disorder 57 (17.6) 
 Mental retardation 27 (8.4) 
 Depression 24 (7.4) 
 Seizures/epilepsy 19 (5.9) 
 Bipolar disorder 11 (3.4) 
 Cerebral palsy 5 (1.7) 
   
Insurance coverage Yes 316 (97.8) 
 No 7 (2.2) 
   
SCQ total score (Mean ± SD)  22.21 ± 6.57 
   
SRS total score (Mean ± SD)  104.14 ± 29.43 
n = Number of individuals; SD = Standard deviation; SCQ: Social communication questionnaire; 
SRS: Social Responsiveness Scale 
 
The unmet healthcare needs among children and parents of children with ASD are 
reported in Table 2. The most important unmet need was the adequacy of child’s health 
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insurance, with nearly 58% parents indicating that the child’s insurance never or 
sometimes covered services that the child needed. Thirty five percent of parents indicated 
needing but not receiving behavioral health services. In addition, approximately 30% of 
parents indicated having unmet needs related to physical/occupational therapy (Table 2). 
 
Table 2: Healthcare and insurance needs 
Variable Level Frequency 
n (%) 
Unmet needs Behavioral therapy 114 (35.4) 
 Speech therapy 100 (31.1) 
 Physical/occupational therapy  96 (29.7) 
 Family mental health 86 (26.6) 
 Respite care 84 (26) 
 Specialty care 64 (19.8) 
 Mental health 54 (16.8) 
 Genetic counselling 43 (13.3) 
 Communication devices 32 (9.9) 
 Supplies 23 (7.1) 
 Prescription medicine 13 (4) 
   
Insurance meets needs Never 32 (9.9) 
 Sometimes 154 (47.7) 
 Usually 100 (31) 
 Always 37 (11.5) 
   
n = Number of individuals 
 
Another important concept that was the focus of this study was the parent-perceived 
quality of healthcare interactions as reported in Table 3. The aspects of quality of 
healthcare interactions included: providers spent enough time at appointments, listened to 
the parents, made sure parents felt like partners in the child’s healthcare decision, were 
sensitive to the parents, and provided all the necessary information to the parents. In 
addition, owing to the large number of services needed by the child, how often parents 
received help with coordinating care of the child was also studied. Although quality of 
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healthcare interactions was found to be acceptable for most children with ASD, a large 
proportion of parents indicated that doctors were unable to provide adequate level of care 
in 20-42% of the cases. A majority of parents (61%) indicated that the frequency of help 
with coordination was low or absent and the healthcare providers’ ability to offer useful 
and 42% parents indicated that doctors rarely offered useful information (See Table 3 for 
more details).     
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Table 3: Quality of healthcare interactions  
Variable 
 
Level Frequency 
n (%) 
Doctor spends appropriate time at appointments Never 8 (2.5) 
 Sometimes 94 (29.1) 
 Usually 124 (38.4) 
 Always 97 (30) 
   
Doctor listens to complains  Never 2 (0.6) 
 Sometimes 67 (20.7) 
 Usually 137 (42.4) 
 Always 117 (36.2) 
   
Doctor sensitive to families’ values Never 12 (3.7) 
 Sometimes 43 (13.4) 
 Usually 131 (40.8) 
 Always 135(42.0) 
   
Doctor provides useful information Never 41 (12.7) 
 Sometimes 94 (29.1) 
 Usually 120 (37.1) 
 Always 68 (21.1) 
   
Doctor treats parent like a partner in child’s care Never 14 (4.3) 
 Sometimes 65 (20.1) 
 Usually 119 (36.8) 
 Always 125 (38.7) 
   
Coordination of care Never 139 (43.2) 
 Sometimes 58 (18) 
 Usually 59 (18.3) 
 Always 66 (20.5) 
   
n = Number of individuals 
 
Research objective 1  
To determine the economic impact of ASD on the families of children with ASD 
Among parents of children with ASD, over 40% indicated having financial problems 
because of child’s health. This was found to be applicable across all levels of income, 
with 43% of parents belonging to a household with total household income greater than 
$100,000 indicating financial problems because of the child’s health. The proportion of 
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parents who indicated having financial problem because of child’s health was highest in 
the income range of $10,000-70,000, ranging from slightly over half to approximately 
two-thirds (Table 4) 
 
Table 4: Financial problems by level of total household income 
 Level Financial problems 
n (%) 
Yes No 
Total household income < $10,000  6 (54.6) 5 (45.4) 
 $10,000-39,999 38 (65.5) 20 (34.5) 
 $40,000-69,999 45 (65.2) 24 (34.8) 
 $70,000-99,999 37 (52.9) 33 (47.1) 
 > $100,000 44 (43.1) 58 (56.9) 
    
n = Number of individuals 
 
Having children with ASD also hindered parental participation in the workforce, with 
78% indicating they had to make changes to their work status to accommodate for their 
child’s needs. A total of 37% stopped working and 41% reduced hours of working (Table 
5).  
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Table 5: Economic impact on family 
Variable 
 
Level Frequency 
n (%) 
Family reduced working hours Yes 132 (41) 
 No  
   
Family stopped working Yes 120 (37) 
 No  
   
Need more income Yes 158 (49) 
 No  
   
Financial problems because of child’s health Yes 173 (53.6) 
 No  
   
Out of pocket payment Nothing 18 (5.6) 
 < $250 40 (12.4) 
 $250-499 47 (14.5) 
 $500-999 44 (13.6) 
 $1,000-4,999 109 (33.8) 
 ≥ $5,000 65 (20.1) 
   
n = Number of individuals 
 
 
Analysis of the patients’ health insurance showed that the majority of patients (80%) 
were insured by one type of insurance and a few patients (18%) had simultaneous 
coverage by two types of insurances. The most common type of insurance was employer-
provided health insurance (76%) and the second highest insurance provider was Medicaid 
with insurance provision to 31% children with ASD. Other types of insurances that 
children were covered under include Children's Health Insurance Program and Military 
Health Plan. Overall, 55% of children with ASD never or sometimes had adequate 
insurance. The proportion was higher among privately insured patients with 60% 
indicating never or sometimes having adequate insurance and 45% patients insured by 
Medicaid indicating never or sometimes having adequate insurance.       
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Figure 5: Type of insurance vs. insurance meets needs 
 
 
 
A chi-square test was conducted to analyze the difference in adequacy of insurance based 
on whether or not a person had private insurance and whether or not a person was 
covered by Medicaid. The results of the chi-square test demonstrated that adequacy of 
insurance showed a statistically significant difference based on the presence or absence of 
private insurance coverage (p = 0.0068) and the presence or absence of Medicaid 
coverage (p = 0.0158). A greater proportion of children covered by Medicaid had 
adequate insurance at most times (54%) as compared to children covered by private 
insurance (40%). Statistically significant differences were observed in out-of-pocket 
payments based on the presence or absence of private insurance coverage (p < 0.001) and 
the presence of absence of Medicaid coverage (p = 0.0006). A greater proportion (62%) 
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of children with Medicaid coverage had out-of-pocket costs under $1000 as compared to 
children with private coverage (38%). 
Research objective 2 
To determine the relationship between financial burden among families of children with 
ASD and coordination of care, unmet needs, access to care, quality of health 
interactions, adequacy of insurance 
The logistic regression analysis showed that the model successfully predicted financial 
burden among families of children with ASD (p < 0.0001) explaining 21% of variance 
for quality of health interactions. The analysis of maximum likelihood estimates showed 
that adequacy of insurance (p = 0.0009), number of unmet needs (p = 0.0005), and having 
insufficient help with coordination (p < 0.0001) were significant predictors of having 
financial problems. Having ‘adequate insurance’ sometimes was associated with a 4.6 
times higher likelihood of having financial problem as compared to ‘having adequate 
insurance’ always. Every unit increase in the number of unmet needs was associated with 
30% increased likelihood of experiencing financial burden. Patients having insufficient 
help with coordination of healthcare were 2.8 times more likely to have financial 
problems as compared to patients having sufficient help with coordination of healthcare. 
The detailed results are presented in Table 6. 
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Table 6: Predictors of quality of financial burden 
Parameter  Level B SE Wald 
Chi-Square 
P OR (CI) 
Intercept   -1.15 0.72 0.25 0.11  
       
Adequacy of insurance  Never 0.33 0.32 1.08 0.29 3.2 (1.2-10.0) 
 Sometimes 0.69 0.21 11.04 <0.01*** 4.7 (1.9-11.4) 
 Usually -0.17 0.22 0.56 0.45 2.0 (0.8-4.9) 
 Alwaysǂ Reference     
       
Unmet needs   0.26 0.08 12.077 <0.01*** 1.3 (1.1-1.5) 
       
Going without care/delaying care No -0.06 0.33 0.15 0.70 0.9 (0.5-1.7) 
 Yesǂ Reference     
       
Quality of healthcare interactions   0.05 0.04 1.14 0.28 1.0 (0.9-1.1) 
       
Sufficient help with coordination of care No 0.52 0.30 11.99 <0.01*** 2.8 (1.5-5.1) 
 Yesǂ Reference     
B = parameter estimate; CI = confidence interval; OR = odds ratio; p = probability; SE = standard error;  
***statistically significant at p <0.001; Dependent variable: Financial burden; R2 = 0.2108; p <0.01* 
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Research objective 3 
To determine the relationship between quality of healthcare interactions and access to 
care, adequacy of insurance, unmet needs, coordination of care, severity of disease 
Internal consistency of quality of health interactions scale 
The quality of health interactions scale showed a strong internal consistency i.e. 
standardized α > 0.85. This means that all questions designed to pertain to quality of 
health interactions were sufficiently correlated with the remaining questions pertaining to 
quality of health interactions.  
Table 7: Cronbach's coefficient alpha - quality of health interactions scale 
Variables Alpha 
  
Raw 0.89 
Standardized 0.89 
  
Multicollinearity diagnostics for quality of health interactions scale 
As seen in Table 8, below tolerance was not found to be an issue as most tolerance values 
were found to be > 0.1. The value of tolerance statistics for the ‘Always’ category of each 
variable was found to be low.  However, this is a common phenomenon when using 
categorical variables with three or more categories even if the variable is not associated 
with other variables. This does not have an impact on the overall regression and was 
therefore determined to be acceptable.  
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Table 8: Multi-collinearity - Quality of health interactions scale 
Variable Level  Tolerance 
Doctor spends appropriate time at appointments  Never 0.66 
 Sometimes 0.30 
 Usually 0.47 
 Alwaysǂ 0 
   
Doctor listens to complains  Never 0.75 
 Sometimes 0.29 
 Usually 0.41 
 Alwaysǂ 0 
   
Doctor sensitive to families’ values  Never 0.61 
 Sometimes 0.44 
 Usually 0.54 
 Alwaysǂ 0 
   
Doctor provides useful information  Never 0.42 
 Sometimes 0.34 
 Usually 0.45 
 Alwaysǂ 0 
   
Doctor treats parent like a partner in child’s care  Never 0.51 
 Sometimes 0.31 
 Usually 0.45 
 Alwaysǂ 0 
ǂReference category 
The results of the internal consistency and multi-collinearity together indicate that the 
quality of care scale was found to have strong internal consistency without redundancy. 
Thus, the variable was appropriate for usage in further analysis. 
Regression analysis to determine predictors of quality of health interactions 
The aim of the regression analysis was to determine the predictors of quality of health 
interactions among children with ASD. The following regression model was tested. 
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For the results of a multiple regression analysis to be valid, a number of assumptions 
must be met: 
 Linear relationship between dependent and independent variables: The variables 
that had a significant correlation were access to care, adequacy of insurance, 
unmet needs, help with coordination, SRS total score and total scores for all SRS 
domains (Table 9). The SCQ total score and total score for all SCQ domains did 
not have a linear relationship with quality of health interactions. Only variables 
with significant correlation were included in the final model to meet the linear 
relationship assumption.  
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Table 9: Correlation analysis for all possible independent variables vs. Quality of healthcare 
interactions 
Variable  Pearson Correlation Coefficient  
  
p 
Delayed or no care -0.37 <0.01* 
Adequacy of insurance 0.32 <0.01* 
Unmet needs -0.45 <0.01* 
Sufficient coordination 0.46 <0.01* 
SCQ total -0.07 0.21 
Communication domain score -0.004 0.93 
Behavior domain score 0.009 0.87 
SRS total score -0.20 <0.01* 
SRS t-score -0.20 <0.01* 
Social communication t-score -0.22 <0.01* 
Social cognition t-score -0.19 <0.01* 
Social motivation t-score -0.20 <0.01* 
Autistic mannerisms t-score -0.12 0.02* 
Awareness t-score -0.15 <0.01* 
*Significant at p < 0.05 
 Error (residuals) should be normally distributed: Many common tests of null 
hypotheses on regression results require normality. The data were found to be 
meet the assumption of normality as p = 0.0149 (i.e. p < 0.05) through the Shapiro 
Wilk’s test (Table 10) 
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Table 10: Tests for normality - quality of care regression analysis 
Test Statistic p Value 
Shapiro-Wilk 0.98  0.01 
 
 Homoscedasticity: No obvious patterns were observed (Figure 6) Hence, no 
heteroscedasticity was identified and assumption of homoscedasticity was met 
Figure 6: Residual vs. predicted values for quality of care regression analysis 
 
 
 Multicollinearity: The tolerance statistic for all variables was found to be > 0.1 
and hence the multicollinearity was not an issue with the analysis (Table 11). The 
tolerance statistic was < 0.1 only for a level of adequacy of insurance. Again, this 
occurs with categorical variables with more than three levels.  
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Table 11: Multi-collinearity diagnostics for independent variables used to predict quality 
of healthcare interactions 
Variable Level Tolerance 
Intercept  5.4 
Going without care/delaying care  0.75 
Adequacy of insurance  Never 0.56 
 Sometimes 0.35 
 Usually  0.39 
 Alwaysǂ  
Unmet needs  0.58 
Sufficient co-ordination  0.78 
Social cognition t-score   0.35 
Social motivation t-score  0.57 
Autistic mannerism score  0.38 
Awareness t-score  0.47 
ǂReference category 
The model was found to significantly predict quality of health interactions (p < 0.0001) 
explaining 36% of variance for quality of health interactions (Table 12). The significant 
predictors of quality of health interactions were access to care, adequacy of insurance, 
unmet needs, sufficient coordination, and social motivation t-score (p < 0.05).  
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Table 12: Predictors of quality of healthcare interactions 
Variable Level B SE CI 
Lower bound 
 
Upper bound 
p 
 
Going without care / Delaying care No 1.37 0.41 0.58 2.17 <0.01* 
 Yes Reference     
       
Adequacy of insurance Never -2.00 0.71 -3.40 -0.59 <0.01* 
 Sometimes -1.53 0.54 -2.60 -0.46 <0.01* 
 Usually 
Always 
-0.80 
Reference 
0.56 -1.90 0.29 0.15 
       
Sufficient coordination of care No -2.20 0.37 -2.92 -1.47 <0.01* 
 Yes Reference     
       
Unmet needs  -0.30 0.09 -0.48 -0.11 <0.01* 
       
Social cognition t-score  -0.02 0.02 -0.06 0.02 0.38 
       
Social motivation t-score  -0.03 0.01 -0.06 -0.004 0.02* 
       
Awareness t-score  0.01 0.02 -0.02 0.05 0.09 
       
Autistic mannerisms domain score  0.02 0.01 0.00 0.05 0.01** 
       
B = Parameter estimate; CI = Confidence interval; p = probability; R2 = variance; SE = Standard Error;  
*Statistically significant at p <0.05; **Statistically significant at p <0.01;***Statistically significant at p <0.001;  
Dependent variable: Quality of healthcare interactions (p < 0.01***); R2 = 0.3629
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Research objective 4 
To determine the relationship between coordination of care and ease of obtaining a 
referral, access to care, adequacy of insurance, unmet needs, quality of healthcare 
interactions, severity of disease 
The logistic regression analysis showed that the model was successful in the prediction of 
sufficient coordination (p < 0.0001) explaining 31% of variance for quality of health 
interactions. The analysis of maximum likelihood estimates showed that ease of obtaining 
referral (p = 0.0002), number of unmet needs (p < 0.0001), and quality of care (p < 
0.0001) were significant predictors of having sufficient help with coordination of care. 
Having ease of referral was associated with a four times higher likelihood of sufficient 
help with coordination. Every unit increase in the number of unmet needs was associated 
with 30% lower likelihood of having sufficient help with coordination. Every unit 
increase in quality of care was associated with a 30% greater likelihood of having 
sufficient help with coordination. (See Table 13 for more details). 
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Table 13: Predictors of care co-ordination 
Parameter  Level B SE Wald 
Chi-Square 
P OR (CI) 
Intercept   -3.59 0.92 15.20 <0.01***  
       
Ease of referral No -0.71 0.19 13.86 <0.01*** 0.24 (0.1 - 0.5) 
 Yes Reference     
       
Adequacy of insurance Never 0.11 0.37 0.08 0.77 0.9 (0.2 - 3.6) 
 Sometimes -0.20 0.23 0.77 0.38 0.7 (0.2 - 1.9) 
 Usually -0.08 0.27 0.09 0.76 0.8 (0.3 - 2.4) 
 Always Reference     
       
Going without care / delaying care No 
Yes 
-0.20 
Reference 
0.18 1.21 0.27 1.4 (0.7 - 2.9) 
       
Unmet needs  -0.33 0.08 16.96 <.01*** 0.7 (0.6 - 0.8) 
       
Total score SCQ    0.03 0.02 1.51 0.22 1.0 (0.98 - 1.1) 
       
Quality of healthcare interactions   0.26 0.05 29.01 <.01*** 1.3 (1.2 - 1.4) 
       
 B = Parameter estimate; CI = Confidence interval; OR = odds ratio; p = probability; ǂReference category; SE = Standard Error;  
***Statistically significant at p <0.001; Dependent variable: Sufficient help with coordination; R2 = 0.3159; p <0.01 
 56 
 
CHAPTER FIVE – DISCUSSION 
Discussion 
The first objective of the study was to explore the economic impact of ASD on families 
as measured by three indicators: having financial problems because of child’s ASD, 
having annual out-of-pocket payments greater than $1000, and having to cut back or stop 
working to account for child’s healthcare needs. The study demonstrated that ASD had a 
considerable impact on families in terms of all three outcomes: 53.6% had financial 
problems because of child’s ASD, 53.9% had out-of-pocket payments greater than 
$1,000, and 78% had to cut back hours or stop working to accommodate for their child’s 
healthcare needs. When compared to the national average among families of children 
with special healthcare needs, the proportion of families with the above-mentioned 
outcomes was higher among families of children with ASD. The national average for 
families of children with special healthcare needs were as follows: 21.6% had financial 
problems because of the child’s health, 22.1% had annual out-of-pocket payments  
greater than $1,000, and 25% had to cut back hours or stop working to accommodate for 
their child’s needs.100  Further exploration of the data demonstrated that having financial 
burden was attributable to having inadequate insurance coverage, but not to the total 
household income. The results were consistent to those observed by another study, which 
reported that greater proportion of families of children with ASD had financial burden as 
compared to families of children with developmental disabilities such as cerebral palsy, 
Down syndrome, developmental delay, or intellectual disability.93 As per the study, 
families of children with ASD were 45% more likely to have financial burden as 
compared to families of children with developmental disabilities.93  
 57 
 
This study also found that, out-of-pocket payments differed significantly based on type of 
insurance, with out-of-pocket costs less than $1000 for 62% families of children with 
Medicaid coverage and out-of-pocket costs less than $1000 for 38% families of children 
with private insurance coverage. The findings were corroborated by another study, which 
demonstrated that the median annual out-of-pocket cost among low-income families (at 
200% federal poverty line) was higher for children who had private insurance coverage 
($623) vs. children who were insured by Medicaid/S-CHIP ($287).78 Although causality 
of this effect was not analyzed in this study, the effect may be attributable in part to the 
lower co-payments and better coverage of services provided by Medicaid as compared to 
private insurance.78  In the current study, 54% of children covered by Medicaid were 
offered benefits that met the child’s needs most of the time as compared to 40% of 
children covered by private insurance. Another study has shown that many of the services 
recommended for children with ASD are often excluded under private plans because they 
are unproven or experimental.101 The most significant finding of the current study with 
respect to health insurance is that despite having insurance children with ASD continue to 
be at a risk of being underinsured; although majority of children (97.8%) were covered 
by some kind of insurance, a limited proportion (11.5%) found the insurance to be 
adequate, including those covered by Medicaid. The study highlights that it may be 
necessary to institute additional provisions for children with ASD to obtain necessary 
services.      
 
The second objective of the study was to identify aspects of the healthcare systems that 
may be associated with financial burden on families of children with ASD. As expected, 
 58 
 
inadequacy of insurance was a significant predictor of financial burden. Children who 
had adequate insurance coverage usually were less likely to have financial burden 
because of child’s health compared to those who had adequate insurance coverage only 
sometimes. In addition, this study identified the number of unmet needs and insufficient 
care coordination as significant predictors of financial burden.  The results of this study 
demonstrate that provision of coordinated care may help reduce financial burden on the 
families, most likely due to the reduced use of inappropriate and costly healthcare 
services. The variable unmet healthcare needs was a proxy variable for measuring 
difficulties with healthcare access. It is noteworthy that having difficulty with access to 
healthcare predicted financial burden beyond that accounted for by inadequacy of 
insurance coverage. While the reasons for this effect were not studied, it is speculated 
that this may be attributable to the shortage of healthcare professionals with sufficient 
qualifications to treat children with ASD.102 Due to the shortage of healthcare 
professionals, caregivers often have to travel far to access services. This may likely have 
an impact on financial burden both directly and indirectly, through lost work 
productivity. In the past, studies have focused on the impact of health insurance on 
financial burden, however, the impact of access issues beyond health insurance  on 
financial burden have not received as much attention.84 This study takes into account both 
insurance as well as other access issues for the prediction of financial burden.  While the 
economic benefits of coordinated care from a payer’s perspective are well-established, 
their financial impact on the families of children with ASD have rarely been studied.103 
This study advocates for the adoption of coordinated and comprehensive care, which is 
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akin to the medical home approach, as a possible means to help reduce financial 
burden.104  
 
The next objective was to identify the relationship between parent-perceived quality of 
healthcare interactions and other aspects of the healthcare system.  As documented in 
other studies, this study found that a large proportion of patients perceived quality of 
healthcare interactions to be acceptable sometimes or never.92 Although studies have 
focused on the measuring level of satisfaction with healthcare interactions91,92, the factors 
that predict satisfaction are not well understood. This study aims to test a model for the 
prediction of quality of healthcare, based on the incorporating different aspects of the 
healthcare systems and symptom severity. The model proposed by this study was a good 
predictor of quality of healthcare interactions, predicting 36% variance in quality of 
healthcare interactions. The results of this study imply that parents perceived the quality 
of healthcare interactions to be better when the child received coordinated care, were able 
to access needed services, and had health insurance to cover those services usually. As 
described previously, this was aligned with the principles of a medical home approach to 
treatment. Thus, based on this study, the adoption of a medical home approach may not 
only reduce family financial burden but also improve parental perceptions of quality of 
healthcare interactions, possibly reducing caregiver burden.103 In addition, this study 
indicated that timeliness of care predicted of parental perceptions of quality of healthcare, 
implying the need for more professionals with specialized training and shorter wait times 
to improve quality of healthcare interactions. This is in line with the recommendations 
proposed by several studies, which recommended the need to provide more training to 
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primary health care providers, so that children with ASD receive early access to 
evidence-based care.105,106,107 Furthermore, this study identified that specific symptoms 
were associated with poor healthcare quality interactions. As per the study, having 
problems with social motivation (i.e. would the child rather be alone or interact with 
others) and autistic mannerisms (i.e. overt reliance on certain routines) were associated 
with lower quality of healthcare interactions. The results of this study add to existing 
evidence that greater symptom severity is associated with lower satisfaction with 
healthcare providers.92  Moreover, the study goes further to explain the specific 
symptoms that are associated with quality of healthcare interactions. While the reasons 
for this were not analyzed, the findings provide an understanding of the specific parental 
concerns that may need to be addressed better by physicians. 
  
The final objective of the study was to understand the predictors of coordination of care. 
This study found the number of unmet needs was a significant predictor of coordination 
of care. This finding is consistent with that observed by another study, which reported 
that patients who did not have coordinated care as defined by a medical home were likely 
to have a higher number of unmet needs as compared to patients who had medical 
homes.108 Other predictors of coordinated care provision include ease of referral and 
quality of healthcare interactions. It is worth noting that adequacy of insurance was not a 
significant predictor of coordinated care, instead coordinated care was associated with 
factors that communicate the quality of healthcare interactions. This further highlights the 
need for increased focus on physician training to improve quality of healthcare 
interactions.94,106,107  
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Limitations 
The limitations of the study must be taken into account while interpreting the results of 
the study. First, the data were provided by the members of a web-based community (the 
IAN). Respondents would have required internet access to be part of the community, 
which may have introduced a selection bias. The study sample consisted of 90% 
Caucasian participants as compared to an actual nationwide proportion of 58%.3 The 
over-representation of subjects from the Caucasian race and higher income families 
reduces generalizability of the findings. The study likely underestimates the financial 
burden among families of children with ASD. Second, the analyses were conducted on 
data previously recorded in the database, whose quality may be limited by systematic or 
recorder bias, data coding-recoding errors, incomplete data, data quality, and 
confounding factors. Third, the data was cross-sectional and did not permit causal 
conclusions. The results prove associations alone. Moreover, the study was limited to the 
data was provided and may not be generalizable. Finally, there is a need to have more 
validated measures for access to specialized and coordinated care. Despite the limitations, 
the findings of the study contribute significantly to the existing literature on access to 
services in ASD and caregiver burden. 
Study Implications 
This study has important implications for a number of healthcare stakeholders.  With the 
rising prevalence of ASD, physicians and managed care organizations are faced with the 
challenge of providing optimal care as well as curtailing the growing cost of providing 
care. This study provides various insights into the issues that affect families of children 
with ASD, which have important implications for a number of stakeholders.  
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From the physicians’ perspective, the study helps physicians understand areas of care that 
are most problematic from the perspective of parents of children with ASD. This can help 
physicians address the areas of parental concern and, in turn, streamline healthcare 
provision and improve outcomes among children with ASD.  Primary physicians should 
provide coordinated care, by interacting with different professionals providing healthcare. 
In addition, physicians should pay special attention to alleviate concerns surrounding 
autism mannerisms and social motivation, as these have been identified as having an 
association with parent-perceived quality of healthcare interactions. 
 
From the perspective of policymakers, this reiterates some of the issues with insurance 
coverage. This can help provide an understanding of the current situation and find ways 
to improve overall healthcare in children and families of children with ASD. 
Policymakers should focus on improving insurance coverage by making sure that both 
private and public insurances cover services needed for the treatment of ASD.  The study 
also provided additional evidence that favors the adoption of the medical homes approach 
to treatment. 
 
From the parents’ perspective, the study identifies other priorities perceived by families, 
which can help policymakers design strategies to tackle these issues. Based on the study, 
strategies that can help families are providing better insurance coverage, improving the 
physician knowledge of ASD treatment, or providing incentives to provide coordinated 
care. Furthermore, the study delineates predictors of financial burden, to help parents 
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make informed decisions about treatments strategies for their children such as finding 
physicians who provide coordinated comprehensive care or using case managers to avoid 
utilization of expensive services without benefit. 
 
From the ASD researchers’ perspective, this study provides a measure of reliability for 
the scale quality of healthcare interactions. Quality of healthcare interactions has been 
identified as an important construct predicting healthcare utilization. The scale used in 
the study has been used in research previously. However, the scale has not been tested for 
reliability. This study provides evidence that the scale has good reliability and can be 
used in future studies.  
Future directions 
This study highlighted that a large proportion of respondents indicated that insurance 
coverage was inadequate. Future studies should try to identify specific services that 
would be beneficial to cover from the parents’ perspective. Furthermore, policies that 
may help provide respite to families in terms of financial burden must be evaluated.  
 
This study highlighted the potential financial benefits of providing coordinated care. 
Further studies of an interventional nature are needed to ascertain this effect. While 
adequacy of insurance was identified to be an important factor for financial burden, the 
study emphasized the importance of other access issues in predicting financial burden on 
families of children with ASD. Future studies should focus on identifying other access-
related issues such as the availability of specialized care in close proximity to the 
residence of the family and the means to improve quality in this respect. Studies should 
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also identify the means needed to improve specialized education in these areas. The study 
also highlights the importance of healthcare access in financial burden and consequently, 
caregiver burden. None of the existing instruments take into account healthcare access 
related issues in measuring caregiver burden. It is important to develop an instrument that 
does so to obtain a more accurate estimation of caregiver burden.            
Conclusion 
Based on this study, the following conclusion can be stated: economic impact among 
families of children with ASD is higher as compared to families of children with 
developmental disorders. Factors related to provision of healthcare were significant 
predictors of financial burden and coordinated care, access to care, and quality of 
healthcare interactions were important components of healthcare for children with ASD. 
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